Mimedx Group Overview
Valuation check: MDXG's ROE is 2.89%, below the Industrials sector average of 22.29%.
Get informed when a big investor buys or sells
+ Follow2.89%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for MDXG is 2.89%. That is below the Industrials sector average of 22.29%. Investors often review this figure alongside Mimedx Group's historical trend and sector peers before judging valuation or financial health.
Against Industrials companies, MDXG currently prints 2.89% for ROE, while the sector average sits near 22.29%. That is roughly 87.0% below the sector mean. Large gaps often invite a closer look at Mimedx Group's growth, margins, and balance sheet.
Return on Equity shows how effectively Mimedx Group converts resources into returns. At 2.89%, MDXG may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MDXG's ROE (2.89%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Mimedx Group's ROE against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.
